DUBLIN--(BUSINESS WIRE)--May 17, 2018--The "Global Drug Substance Manufacturing - Procurement Market Intelligence Report" report has been added to ResearchAndMarkets.com's offering.

The report provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

The report provides actionable insights to improve source-to-contract cycle performance in the Global Drug Substance Manufacturing Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.

One of the best procurement practices for the buyers is to engage with suppliers that implement flexible production practices such as virtual engineering.

According to the report, a major growth driver of this market includes the demand for pharmaceutical drugs, which is increasing owing to the rise in aging population and chronic disease levels.

Further, the report states that a key procurement challenge faced by buyers is the difficulty in forecasting biologic drug production. The biologics drug development and approval process are long and fraught with complications, resulting in risk of inaccurately demand forecasting.

Companies Mentioned

Pfizer CentreOne CEPiA GSK Dr. Reddy's Patheon

Key Topics Covered

1. Category at a Glance

2. Scope of the Report

3. Market Insights

4. Supply Market Insights

5. Pricing Insights

6. Procurement Insights

7. Top Five Suppliers

For more information about this report visit https://www.researchandmarkets.com/research/pm23mn/drug_substance?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180517006206/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceutical Manufacturing,Addiction Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 05/17/2018 01:51 PM/DISC: 05/17/2018 01:51 PM

http://www.businesswire.com/news/home/20180517006206/en